A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
Belgium- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to Belgium4 clinical trials in Eeklo, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
Belgium
Belgium
Belgium
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on colon cancer treatment and survival outcomes. These trials are evaluating the potential benefits of common medications in cancer recurrence prevention.
The research explores how acetylsalicylic acid therapy might improve long-term survival rates for patients who have undergone colon cancer surgery, particularly those with stage II and III disease.
Groundbreaking studies examining the role of daily aspirin therapy in preventing cancer recurrence. This research aims to establish new standards in post-operative care protocols.
These trials investigate how common medications might be repurposed to provide additional benefits in cancer care, focusing on five-year survival rates.
Advanced research targeting improved outcomes for patients with resected colon carcinoma. The studies focus on post-surgical intervention strategies to enhance patient survival.
This research explores novel approaches to managing post-surgical cancer patients, with an emphasis on long-term survival and quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.